Novozymes A/S (OTCMKTS:NVZMY) Stock Passes Below 200-Day Moving Average – Time to Sell?

Novozymes A/S (OTCMKTS:NVZMY)’s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $60.87 and traded as low as $57.91. Novozymes A/S shares last traded at $59.45, with a volume of 45,662 shares traded.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on NVZMY. Kepler Capital Markets raised Novozymes A/S from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, May 13th. Rothschild & Co Redburn raised Novozymes A/S to a “strong-buy” rating in a research note on Friday, March 27th. Finally, Zacks Research lowered Novozymes A/S from a “hold” rating to a “strong sell” rating in a research note on Monday, May 4th. Two research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy”.

Novozymes A/S Trading Up 2.1%

The company has a current ratio of 0.72, a quick ratio of 0.44 and a debt-to-equity ratio of 0.12. The business has a 50 day moving average of $58.59 and a 200-day moving average of $60.87. The stock has a market cap of $24.64 billion, a PE ratio of 40.17, a price-to-earnings-growth ratio of 1.09 and a beta of 0.98.

Novozymes A/S (OTCMKTS:NVZMY) last posted its earnings results on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.31). Novozymes A/S had a net margin of 14.22% and a return on equity of 6.57%. The company had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. On average, analysts anticipate that Novozymes A/S will post 2.43 EPS for the current year.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).